ATE329583T1 - Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib - Google Patents

Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib

Info

Publication number
ATE329583T1
ATE329583T1 AT01964122T AT01964122T ATE329583T1 AT E329583 T1 ATE329583 T1 AT E329583T1 AT 01964122 T AT01964122 T AT 01964122T AT 01964122 T AT01964122 T AT 01964122T AT E329583 T1 ATE329583 T1 AT E329583T1
Authority
AT
Austria
Prior art keywords
molded article
preparation containing
medicinal preparation
rapidly dissolving
oral medicinal
Prior art date
Application number
AT01964122T
Other languages
English (en)
Inventor
Tugrul T Kararli
Mark J Kontny
Trang T Le
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Application granted granted Critical
Publication of ATE329583T1 publication Critical patent/ATE329583T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
AT01964122T 2000-08-18 2001-08-17 Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib ATE329583T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22648700P 2000-08-18 2000-08-18

Publications (1)

Publication Number Publication Date
ATE329583T1 true ATE329583T1 (de) 2006-07-15

Family

ID=22849097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964122T ATE329583T1 (de) 2000-08-18 2001-08-17 Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib

Country Status (14)

Country Link
US (1) US20020071857A1 (de)
EP (1) EP1309315B1 (de)
JP (1) JP2004506680A (de)
AT (1) ATE329583T1 (de)
AU (1) AU2001285011A1 (de)
CA (1) CA2419592A1 (de)
CY (1) CY1105319T1 (de)
DE (1) DE60120710T2 (de)
DK (1) DK1309315T3 (de)
ES (1) ES2265439T3 (de)
MX (1) MXPA03001407A (de)
NZ (1) NZ524124A (de)
PT (1) PT1309315E (de)
WO (1) WO2002015884A2 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04002798A (es) * 2001-09-26 2004-07-05 Pharmacia Corp Composiciones de valdecoxib de disgregacion intraoral.
BR0213152A (pt) * 2001-10-10 2004-10-19 Pharmacia Corp Composições de valdecoxib de desintegração intraoral preparadas por processo de secagem por pulverização
WO2003049720A1 (en) * 2001-12-07 2003-06-19 Merck & Co., Inc. Combination therapy comprising a cyclooygenase-2 inhibitor
WO2004000284A1 (en) * 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
WO2004026235A2 (en) * 2002-09-20 2004-04-01 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
CA2477923C (en) * 2002-03-01 2021-02-23 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
WO2004100857A2 (en) * 2003-05-07 2004-11-25 Akina, Inc. Highly plastic granules for making fast melting tablets
BRPI0302736B8 (pt) * 2003-06-02 2021-05-25 Ems S/A composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
EP1832288B1 (de) * 2004-12-27 2012-06-20 Astellas Pharma Inc. Stabile granulatförmige pharmazeutische zusammensetzung von solifenacin oder seinem salz
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
SG160364A1 (en) * 2005-03-07 2010-04-29 Bayer Schering Pharma Ag Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
WO2007011349A1 (en) * 2005-07-15 2007-01-25 Teva Pharmaceutical Industries Ltd. Novel granulation process and granulate produced therefrom
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
CN101820838B (zh) * 2007-08-07 2013-06-05 阿塞尔Rx制药有限公司 采用口腔经粘膜剂型的用于程序镇静和镇痛的组合物和方法
US20100233272A1 (en) * 2007-11-15 2010-09-16 Leah Elizabeth Appel Dosage forms comprising celecoxib providing both rapid and sustained pain relief
CN102056568B (zh) 2008-06-04 2013-08-21 高露洁-棕榄公司 具有气穴系统的口腔护理器具
US20100075930A1 (en) * 2008-09-03 2010-03-25 Yoel Ovil Salicylic salt compositions and related method of treatment of cardiac conditions
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
JP2015531785A (ja) * 2012-09-13 2015-11-05 シービーエー・ファーマ・インコーポレイテッドＣｂａ Ｐｈａｒｍａ，Ｉｎｃ． テトランドリン医薬製剤及び方法
BR112017013311B1 (pt) 2014-12-23 2022-05-31 Acelrx Pharmaceuticals, Inc Aparelho para a dispensação de formas de dosagem via oral e transmucosal
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
US10350171B2 (en) 2017-07-06 2019-07-16 Dexcel Ltd. Celecoxib and amlodipine formulation and method of making the same
CA3088728A1 (en) * 2018-01-21 2019-07-25 Bernie D. KASTNER Migraine treatment preparation and method

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5466464A (en) * 1991-12-24 1995-11-14 Yamanouchi Pharmaceutical Co., Ltd. Intrabuccally disintegrating preparation and production thereof
DE69331839T2 (de) * 1992-01-29 2002-12-12 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
SK74396A3 (en) * 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
CN1140267C (zh) * 1996-05-17 2004-03-03 麦克公司 治疗环加氧酶-2介导的疾病的每天一次的组合物
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
IT1298732B1 (it) * 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
AU764875B2 (en) * 1998-11-12 2003-09-04 Merck & Co., Inc. Combination of a GABA-A alpha 5 inverse agonist and COX-2 inhibitor, NSAID, estrogen or vitamin
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
WO2001039749A2 (en) * 1999-11-30 2001-06-07 Panacea Biotec Limited Fast dissolving composition with prolonged sweet taste

Also Published As

Publication number Publication date
DE60120710D1 (de) 2006-07-27
EP1309315A2 (de) 2003-05-14
JP2004506680A (ja) 2004-03-04
ES2265439T3 (es) 2007-02-16
WO2002015884A2 (en) 2002-02-28
CY1105319T1 (el) 2010-03-03
WO2002015884A3 (en) 2002-07-25
US20020071857A1 (en) 2002-06-13
DK1309315T3 (da) 2006-10-09
AU2001285011A1 (en) 2002-03-04
CA2419592A1 (en) 2002-02-28
PT1309315E (pt) 2006-09-29
MXPA03001407A (es) 2003-06-06
NZ524124A (en) 2004-09-24
EP1309315B1 (de) 2006-06-14
DE60120710T2 (de) 2007-06-14

Similar Documents

Publication Publication Date Title
ATE329583T1 (de) Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib
Masih et al. Fast dissolving tablets: a review
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
EP1120109A3 (de) Feste schnell zerfallende und sich auflösende Dosierungsformen
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
ES2006649A6 (es) Una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico y procedimiento para la obtencion de la misma.
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
CN101371845A (zh) 一种用于治疗口腔溃疡药物组合物
WO2012173581A4 (en) Thiocolchicoside, etodolac and famotidine combinations
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
SE8901003D0 (sv) Snabbloesliga preparat
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
Kapse et al. Co-processed superdisintegrants: Novel technique for design orodispersible tablets
ES2122630T3 (es) Forma medicamentosa de carbamazepina con liberacion retardada del principio activo.
JP6469234B2 (ja) 超速崩壊錠剤及びその製造方法
DE60103276D1 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
PL369121A1 (en) Disposable vaginal cannula for the simultaneous administration of drugs in different forms
Gupta et al. Novel study in fast dissolving drug delivery system: a review
WO2010019279A8 (en) Pharmaceutical compositions configured to deter dosage form splitting
Pandey et al. Orodispersible tablets-a review
CO5160319A1 (es) Formulaciones de liberacion controlada de metamizol
WO2019083483A2 (en) A vaginal implant

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1309315

Country of ref document: EP

REN Ceased due to non-payment of the annual fee